The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review | ||
| dc.conicet.organizacion | Queens University | |
| dc.conicet.organizacion | Queens University | |
| dc.conicet.organizacion | University of Toronto | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental | |
| dc.conicet.organizacion | Cleveland University | |
| dc.conicet.organizacion | Queens University | |
| dc.contributor.author | Shah, Aryan | |
| dc.contributor.author | Ding, Yu | |
| dc.contributor.author | Walji, David | |
| dc.contributor.author | Rabinovich, Gabriel Adrián | |
| dc.contributor.author | Pelletier, Marc | |
| dc.contributor.author | El Diasty, Mohammad | |
| dc.date.issued | 2024-10 | |
| dc.description.abstract | Objective: To review the utility of galectin-3 (Gal-3) as a biomarker for postoperative adverse outcomes in patients undergoing cardiac surgery. Method: This review was conducted in compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Electronic database search was conducted in October 2023. Studies that measured pre- and/or postoperative plasma Gal-3 levels in adult patients undergoing cardiac surgery were included. Primary outcomes included postoperative morbidity and mortality. Results: Out of 391 studies screened, eight studies met the inclusion criteria. Two of the three studies showed that preoperative plasma levels of Gal-3 were associated with acute kidney injury (AKI) after cardiac surgery. Two of the three studies reported a significant increase in preoperative Gal-3 levels in patients who developed postoperative atrial fibrillation (POAF). The addition of Gal-3 to the EuroSCORE II model was found to statistically improve the prediction of both AKI and POAF. Three of the five studies suggested that Gal-3 levels can predict postoperative mortality. Finally, one study suggested that lower preoperative Gal-3 levels was associated with a higher likelihood of achieving left ventricular reverse remodeling (LVRR) after surgery. Conclusions: Gal-3 may play a promising role in predicting adverse outcomes in patients undergoing cardiac surgery. The addition of Gal-3 to clinical risk prediction scores may improve their discriminatory power in this group of patients. Future studies are warranted to justify its incorporation into routine clinical practice. | es_ES |
| dc.description.fil | Fil: Shah, Aryan. Queens University; Canadá | |
| dc.description.fil | Fil: Ding, Yu. Queens University; Canadá | |
| dc.description.fil | Fil: Walji, David. University of Toronto; Canadá | |
| dc.description.fil | Fil: Rabinovich, Gabriel Adrián. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina | |
| dc.description.fil | Fil: Pelletier, Marc. Cleveland University; Estados Unidos | |
| dc.description.fil | Fil: El Diasty, Mohammad. Queens University; Canadá | |
| dc.format | application/pdf | es_ES |
| dc.identifier.citation | Shah, Aryan; Ding, Yu; Walji, David; Rabinovich, Gabriel Adrián; Pelletier, Marc; et al.; The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review; Taylor & Francis Ltd; Biomarkers; 29; 7; 10-2024; 485-493 | es_ES |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1354-750X | es_ES |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/300717 | |
| dc.journal.ciudad | Londres | es_ES |
| dc.journal.number | 7 | es_ES |
| dc.journal.pagination | 485-493 | es_ES |
| dc.journal.pais | Reino Unido | es_ES |
| dc.journal.title | Biomarkers | es_ES |
| dc.journal.volume | 29 | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Taylor & Francis Ltd | es_ES |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.tandfonline.com/doi/full/10.1080/1354750X.2024.2415073 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1080/1354750X.2024.2415073 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | |
| dc.subject | GALECTIN-3 | es_ES |
| dc.subject | CARDIAC SURGERY | es_ES |
| dc.subject | INFARCTION | es_ES |
| dc.subject | INFLAMMATION | es_ES |
| dc.subject.classification | Sistemas Cardíaco y Cardiovascular | es_ES |
| dc.subject.classification | Medicina Clínica | es_ES |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es_ES |
| dc.title | The prognostic utility of galectin-3 in patients undergoing cardiac surgery: a scoping review | es_ES |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.0ac030ab-b140-4f3b-908a-c647aa258ba3_B.pdf
- Tamaño:
- 1.77 MB
- Formato:
- Adobe Portable Document Format